SCHEMBL6034071

SCHEMBL6034071

Cc1c(N)ncnc1-c1ccc2cccnc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
SRC P12931 7/20 0.48
KDR P35968 6/20 0.48
PIK3CD O00329 6/20 0.48
ABL1 P00519 5/20 0.48
EGFR P00533 5/20 0.48
HCK P08631 5/20 0.48
PIK3CA P42336 5/20 0.48
PIK3CB P42338 5/20 0.48
MTOR P42345 5/20 0.48
PIK3CG P48736 5/20 0.48
EPHB4 P54760 5/20 0.48
PRKDC P78527 5/20 0.48
BACE1 P56817 1/20 0.46
PI4KB Q9UBF8 1/20 0.46
ADORA2A P29274 3/20 0.43
MEN1 O00255 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6034078 0.84 SRC (0.46) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033645 0.83 KDM5B (0.51) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033528 0.83 NR4A2 (0.49) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033768 0.83 ALDH1A1 (0.49) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033590 0.82 SRC (0.46) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6480365 0.82 SRC (0.48) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033060 0.82 SRC (0.46) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033037 0.80 TRPV1 (0.44) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033785 0.79 ALDH1A1 (0.44) ALDH1A1SRCKDRPIK3CDABL1
SCHEMBL6033745 0.78 ALDH1A1 (0.43) ALDH1A1SRCKDRPIK3CDABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101035780-A Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain MERCK SHARP & DOHME (GB) 2007-09-12 CN disclosed
EP-1685124-A1 SUBSTITUTED NITROGEN-CONTAINING SIX-MEMBERED AMINO-HETEROCYCLES AS VANILLOID-1 RECEPTOR ANTAGONISTS FOR TREATING PAIN MERCK SHARP & DOHME LTD. (GB) 2006-08-02 EP disclosed
US-20050197342-A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain HOLLINGWORTH GREGORY J (GB) 2005-09-08 US disclosed
WO-2005047280-A1 SUBSTITUTED NITROGEN-CONTAINING SIX-MEMBERED AMINO-HETEROCYCLES AS VANILLOID-1 RECEPTOR ANTAGONISTS FOR TREATING PAIN MERCK SHARP & DOHME LIMITED (GB) 2005-05-26 WO disclosed
WO-2005047279-A1 SUBSTITUTED NITROGEN-CONTAINING SIX-MEMBERED AMINO-HETEROCYCLES AS VANILLOID-1 RECEPTOR ANTAGONISTS FOR TREATING PAIN MERCK SHARP & DOHME LIMITED (GB) 2005-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197342-A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain OPRL1, OPRK1, CNR1 ALDH1A1 2879/4885SRC 2181/4885KDR 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.